NASDAQ: GDTC
Cytomed Therapeutics Ltd Earnings Dates, Reports, Calls

Cytomed Therapeutics earnings were -$2.4M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest GDTC earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GDTC reported annual earnings of -$3.1M, with 34% growth.

GDTC earnings history

Current Revenue
$0.0
Current Earnings
-$2.3M
Current Profit Margin
0%

GDTC Return on Equity

Current Company
-26.3%
Current Industry
22.8%
Current Market
33.7%
GDTC's Return on Equity (-26.3%)... subscribe to Premium to read more.
High Return on Equity Performance

GDTC Return on Assets

Current Company
-24.7%
Current Industry
3.5%
GDTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GDTC announces earnings.

GDTC Return on Capital Employed

Current Company
-28.83%
Current Industry
21.3%

GDTC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GDTC-$2.11M-$2.39MN/A-$0.20
ANTX-$60.70M-$60.70MN/A-$1.99
MDCXN/AN/AN/AN/A
GRCE-$15.07M-$11.61MN/A-$1.01
PMN-$391.76k-$563.35kN/A-$0.10

Cytomed Therapeutics Earnings Reports & History FAQ

What were Cytomed Therapeutics's earnings last quarter?

Cytomed Therapeutics (NASDAQ: GDTC) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total GDTC earnings for the quarter were N/A. In the same quarter last year, Cytomed Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Cytomed Therapeutics stock.

Is Cytomed Therapeutics profitable or losing money?

As of the last Cytomed Therapeutics earnings report, Cytomed Therapeutics is currently losing money. Cytomed Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$2.25 million, a 28.66% decrease year over year.

What was GDTC's earnings growth in the past year?

As of Cytomed Therapeutics's earnings date in Q1 2025, Cytomed Therapeutics's earnings has grown year over year. GDTC earnings in the past year totalled -$2.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.